drugset / Trial / NCT06465238
Clinical Study of SHR-A1921 or SHR-A2009 in Previously Treated Advanced NSCLC
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study is an open-label Phase II clinical trial to evaluate the safety and efficacy of SHR-A1921 or SHR-A2009 in patients with advanced NSCLC who progressed after standard therapy.
Timeline
- Start
- 2024-06
- Primary completion
- 2026-06
- Completion
- 2027-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SHR-A1921 | Monoclonal antibody | — | Intravenous |
| Subject | SHR-A2009 | Other / unclassified | — | Intravenous |